Fucoidan for Lung Cancer Therapy: A Review of Classification, Mechanisms, and Preclinical Studies
ACS Omega · 20.11.2025
DOI: 10.1021/acsomega.5c08144 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Omega, online erschienen am 20.11.2025. Verfasst von Nguyen Thi Thanh Uyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria 3083, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: RMIT University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria 3083, Australia.
- School of Science, Engineering & Technology, RMIT University, Ho Chi Minh City 70000, Vietnam.
- School of Science, STEM College, RMIT University, Melbourne 3000, Australia.
- Laboratory of Biophysics, Institute for Advanced Study in Technology, Ton Duc Thang University, Ho Chi Minh City 72915, Vietnam.
- Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 72915, Vietnam.
ORCID-Profile: Son Tung Ngo
Förderung
- RMIT University
Zitieren
APA
Uyen, N. T. T., Yang, A. W. H., Nguyen, Q. N., Hung, A., Ngo, S. T., & Lenon, G. B. (2025). Fucoidan for Lung Cancer Therapy: A Review of Classification, Mechanisms, and Preclinical Studies. ACS Omega. https://doi.org/10.1021/acsomega.5c08144
Vancouver
Uyen NTT, Yang AWH, Nguyen QN, Hung A, Ngo ST, Lenon GB. Fucoidan for Lung Cancer Therapy: A Review of Classification, Mechanisms, and Preclinical Studies. ACS Omega. 2025. doi:10.1021/acsomega.5c08144
BibTeX
@article{Uyen2025,
author = {Uyen, Nguyen Thi Thanh and Yang, Angela Wei Hong and Nguyen, Quynh-Anh Ngoc and Hung, Andrew and Ngo, Son Tung and Lenon, George Binh},
title = {Fucoidan for Lung Cancer Therapy: A Review of Classification, Mechanisms, and Preclinical Studies},
journal = {ACS Omega},
year = {2025},
doi = {10.1021/acsomega.5c08144}
}
EUVIMED